Effect of diabetes mellitus and fibrinogen level on platelet inhibition with clopidogrel therapy /
Ibrahim Mohammed Hamood Ali
Effect of diabetes mellitus and fibrinogen level on platelet inhibition with clopidogrel therapy / تأثير مرض السكرى و مستوى الفيبرينوجين على تثبيط الصفائح الدموية مع العلاج بعقار كلوبيدوجريل Ibrahim Mohammed Hamood Ali ; Supervised Zeinab Attia Ashour , Amr Hassan Mostafa , Maguib Zoheir Mostafa - Cairo : Ibrahim Mohammed Hamood Ali , 2012 - 115 P. : charts ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Cardiology
The goal of this study was to identify factors associated with higher platelet aggregation following clopidogrel therapy in subjects with acute coronary syndrome(ACS). A heterogeneous platelet reactivity response to clopidogrel exists, and the clinical or biochemical predictors of suboptimal platelet inhibition with clopidogrel remain unclear. This study was conducted on 62 subjects with ACS requiring treatment with clopidogrel 75 mg daily for 7 days or more
ACS Clopidogrel therapy Fibrinogen
Effect of diabetes mellitus and fibrinogen level on platelet inhibition with clopidogrel therapy / تأثير مرض السكرى و مستوى الفيبرينوجين على تثبيط الصفائح الدموية مع العلاج بعقار كلوبيدوجريل Ibrahim Mohammed Hamood Ali ; Supervised Zeinab Attia Ashour , Amr Hassan Mostafa , Maguib Zoheir Mostafa - Cairo : Ibrahim Mohammed Hamood Ali , 2012 - 115 P. : charts ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Cardiology
The goal of this study was to identify factors associated with higher platelet aggregation following clopidogrel therapy in subjects with acute coronary syndrome(ACS). A heterogeneous platelet reactivity response to clopidogrel exists, and the clinical or biochemical predictors of suboptimal platelet inhibition with clopidogrel remain unclear. This study was conducted on 62 subjects with ACS requiring treatment with clopidogrel 75 mg daily for 7 days or more
ACS Clopidogrel therapy Fibrinogen